烟台双塔食品股份有限公司 证券代码：002481 证券简称：双塔食品 编号：2026-004 烟台双塔食品股份有限公司 | 招远 | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 市金 岭金 | 926,609 | 0.08% | -- | -- | -- | -- | -- | -- | 926,609 | 100% | | 矿 | | | | | | | | | | | | 合计 | 404,176, | 32.76 | 247,380 | 251,580 | 62.25% | 20.39% | 0 | 0.0% | 926,609 | 0.61% | | | 746 | % | ,000 | ,000 | | | | | | | 烟台双塔食品股份有限公司 关于控股股东部分股份进行质押的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 烟台双塔食品股份有限公司（以下简称"双塔食品"或"公司"）近日接到控 股股东招远君兴农 ...

烟台双塔食品股份有限公司 证券代码：002481 证券简称：双塔食品 编号：2026-003 烟台双塔食品股份有限公司（以下简称"双塔食品"或"公司"）近日接到控 股股东招远君兴农业发展中心（以下简称"君兴农业"）函告，获悉其持有本公司 的部分股份解除质押及再质押，具体事项如下： 一、本次解除质押基本情况 | 股东名 | 是否为控股 股东或第一 | 本次解除质 | 占其所持 | 占公司总 | 质押起始日 | 质押解除日 | 质权人 | | --- | --- | --- | --- | --- | --- | --- | --- | | 称 | 大股东及其 | 押股份数量 | 股份比例 | 股本比例 | | | | | | 一致行动人 | | | | | | | | 君兴 | 是 | 4,000,000 | 0.99% | 0.32% | 2025.3.6 | 2026.3.6 | 齐鲁银行股份 有限公司烟台 | | 农业 | | | | | | | | | | | | | | | | 招远支行 | 二、本次质押基本情况 | | 是否为控 股股东或 | 本次质 | 占其 | 占公 | 是否 | 是否 | 质押 ...

Group 1 - The core viewpoint of the article indicates that Double Tower Foods (002481) has shown stable performance in trading on February 24, 2026, with a latest stock price of 4.99 yuan, reflecting a 0.60% increase from the previous close [1] - The stock experienced a fluctuation of 0.81% on the same day, with a transaction amount of 26.53 million yuan, while the main capital showed a net outflow of 2.3853 million yuan, contrasting with a net inflow from retail investors [1] - Over the past five days, the stock price has cumulatively decreased by 2.92%, underperforming compared to the Shanghai Composite Index, which rose by 1.10% during the same period [1] Group 2 - As of February 24, 2026, the financing and securities balance for Double Tower Foods stands at 257 million yuan, marking a decline of 2.01% from the previous day [1] - On February 13, there was a net selling of 5.264 million yuan in financing, alongside a net purchase of 300 shares in securities lending; the financing activities have shown a mixed trend over the last 20 trading days [1] - The ongoing anti-dumping investigation by the EU regarding pea protein imports from China is still in progress, but there have been no recent updates disclosed [1]

Core Viewpoint - Double Tower Food, the world's largest pea protein producer, is facing significant performance decline, with a projected net profit of 28 million to 40 million yuan for 2025, representing a year-on-year decrease of 70.41% to 57.72% [1] Group 1: Financial Performance - The company reported an asset impairment loss of 68.9884 million yuan in the first three quarters of 2025, an increase of 40.42% compared to the beginning of the period, primarily due to increased inventory of starch and higher provisions for inventory depreciation [1] - In 2021 and 2022, the company's net profit was 268 million yuan and -311 million yuan, reflecting year-on-year declines of 24.12% and 216% respectively [2] - The company experienced a recovery in 2023, with net profits of 93 million yuan and 95 million yuan for 2023 and 2024, showing year-on-year growth of 130% and 1.48% respectively [2] Group 2: Market Challenges - The decline in performance is attributed to external trade friction and internal price cycles, with high raw material costs and falling prices in the pea starch market leading to increased inventory impairment provisions [3] - The European Union initiated an anti-dumping investigation against Chinese pea protein on September 1, 2025, affecting products with protein content over 65%, which could impact the company's export sales [1] Group 3: Strategic Initiatives - The company is actively expanding into emerging international markets and enhancing domestic market development, with domestic sales revenue increasing by 15.63% year-on-year in the first half of 2025 [3] - The company has established a factory in Thailand, which has commenced production, indicating efforts to strengthen its international presence [3] - Experts suggest that the company has core competitive advantages in the domestic plant protein market but faces challenges from intense competition and a relatively weak brand influence [3]

Core Viewpoint - Double Tower Food, the world's largest pea protein producer, is facing significant pressure on its performance, with a projected net profit decline of 70.41% to 57.72% for 2025 compared to the previous year due to challenges in overseas exports and a decrease in pea starch prices leading to asset impairment [1][3]. Financial Performance - The company anticipates a net profit of 28 million to 40 million yuan for 2025, reflecting a substantial decline [1]. - For the first three quarters of 2025, asset impairment losses reached -68.99 million yuan, an increase of 40.42% from the beginning of the period, attributed to rising starch inventory and increased provisions for inventory depreciation [3]. - In 2021 and 2022, the company's net profits were 268 million yuan and -311 million yuan, respectively, showing a year-on-year decline of 24.12% and 216% [4]. - In contrast, the company saw a recovery in 2023 and 2024, with net profits of 93 million yuan and 95 million yuan, representing year-on-year growth of 130% and 1.48% [4]. Market Challenges - The European Union initiated an anti-dumping investigation against Chinese pea protein on September 1, 2025, affecting products with protein content exceeding 65% on a dry weight basis, with the sales of affected products accounting for 3.92% of total revenue in 2024 and increasing to 6.48% in the first half of 2025 [3]. - The company is experiencing dual pressures from external trade friction and internal price cycles, which have highlighted its limited bargaining power in the supply chain and the vulnerability of its business structure [4]. Strategic Initiatives - The company is actively expanding into emerging international markets and enhancing its domestic market presence, with domestic sales revenue increasing by 15.63% year-on-year in the first half of 2025, raising its revenue share to 53.89% [4]. - The Thai factory has been completed and is now operational, contributing to the company's international expansion efforts [4]. Competitive Positioning - As a leader in the pea protein market, the company possesses scale production capacity and mature production technology, providing a competitive edge [5]. - However, the domestic market faces intense competition, and the company's previous focus on B2B rather than B2C has resulted in relatively weak brand influence and a limited product matrix [5]. - There is potential for the company to leverage its production advantages to penetrate the domestic plant-based milk and meat markets while enhancing brand development and product innovation [5].

Group 1 - The core point of the article is that Shuangta Food has announced that its controlling shareholder, Junxing Agriculture, has pledged 4 million shares, which raises concerns about the financial stability of the company [1] - As of the announcement date, Junxing Agriculture has pledged a total of approximately 247 million shares, representing 61.22% of its total holdings [1] Group 2 - The article also mentions the bankruptcy and liquidation of Baolide, a major automotive sales company known for selling luxury cars like Rolls-Royce and Porsche, indicating a significant shift in the automotive sales industry [1] - The headquarters in Hangzhou has been vacated, and the subsidiary in Yiwu has been sealed, highlighting the operational challenges faced by the company [1]

烟台双塔食品股份有限公司 证券代码：002481 证券简称：双塔食品 编号：2026-002 烟台双塔食品股份有限公司 烟台双塔食品股份有限公司 | 招远 | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 市金 岭金 | 926,609 | 0.08% | -- | -- | -- | -- | -- | -- | 926,609 | 100% | | 矿 | | | | | | | | | | | | 合计 | 404,176, | 32.76 | 242,880 | 246,880 | 61.08% | 19.69% | 0 | 0.0% | 926,609 | 0.59% | | | 746 | % | ,000 | ,000 | | | | | | | 1、公司控股股东及其一致行动人本次质押与上市公司生产经营需求无关。 关于控股股东部分股份进行质押的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 烟台双塔食品股份有 ...

Core Viewpoint - Double Tower Food (002481.SZ) forecasts a significant decline in net profit for the fiscal year 2025, with expected earnings between 28 million to 40 million yuan, representing a year-on-year decrease of 57.72% to 70.41% [1] Financial Performance - The net profit attributable to shareholders is projected to be between 28 million to 40 million yuan, a decline of 57.72% to 70.41% year-on-year [1] - The net profit after deducting non-recurring gains and losses is expected to be between 25 million to 37 million yuan, reflecting a decrease of 55.61% to 70.01% year-on-year [1] - Basic earnings per share are estimated to be between 0.022 yuan to 0.032 yuan [1] Business Challenges - The overseas export business of pea protein has been significantly impacted [1] - The decline in the selling price of pea starch has led to asset impairment provisions [1]

Core Viewpoint - Double Tower Foods (002481.SZ) forecasts a significant decline in net profit for the fiscal year 2025, with expected earnings between 28 million to 40 million yuan, representing a year-on-year decrease of 57.72% to 70.41% [1] Financial Performance - The net profit attributable to shareholders is projected to be between 28 million to 40 million yuan, a decline of 57.72% to 70.41% year-on-year [1] - The net profit after deducting non-recurring gains and losses is expected to be between 25 million to 37 million yuan, reflecting a decrease of 55.61% to 70.01% year-on-year [1] - Basic earnings per share are estimated to be between 0.022 yuan to 0.032 yuan [1] Business Challenges - The overseas export business of pea protein has been significantly impacted, contributing to the decline in profitability [1] - The decrease in the selling price of pea starch has led to asset impairment provisions, further affecting financial results [1]

Core Viewpoint - ST Xiangxue expects a net profit loss of 635 million to 934 million yuan for the year 2025, primarily due to intensified market competition, liquidity crisis, high financial costs, and asset impairment [1] Group 1: Financial Performance - The company anticipates a significant loss in net profit for 2025, ranging from 635 million to 934 million yuan [1] - Factors affecting performance include increased market competition, liquidity issues, high financial expenses, and asset impairment [1] Group 2: Business Operations - Despite short-term operational challenges, the overall business situation remains normal, and the company aims to enhance profitability for sustainable operations [1] - The company has made significant progress in innovative drug research and development [1] Group 3: R&D Achievements - The company's subsidiary, Xiangxue Life Science Technology, has received clinical approval for the TCR-T cell therapy product "XLS-103 Injection" for treating advanced non-small cell lung cancer and advanced pancreatic cancer with specific genetic mutations [1] - This approval marks the sixth and seventh clinical trial permits obtained by Xiangxue Life Science based on its core TCR-T cell therapy technology and R&D platform [1] - The company has established a comprehensive platform covering antigen peptide discovery, TCR affinity optimization, and full-process development, with three TCR-T products targeting various solid tumors [1]